The biosurgery market size is expected to reach USD 41.00 billion by 2034, according to a new study by Polaris Market Research. The report “Biosurgery Market Share, Size, Trends, Industry Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Attachments, Others), By Application, By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Biosurgery is a specialized medical field that utilizes natural biological organisms or substances to support surgical procedures, thereby promoting healing and minimizing complications. Surgeons employ maggot debridement, leeches, enzymes, or other biological agents to treat wounds, remove dead tissue, or improve blood flow. These methods offer a minimally invasive alternative to traditional surgery, benefiting patients who cannot undergo conventional procedures due to health risks.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/biosurgery-market/request-for-sample
Biosurgery offers several advantages, including lower infection rates, reduced scarring, and faster recovery times compared to conventional surgery. It also benefits patients with compromised immune systems or those at high risk for anesthesia complications. However, practitioners must carefully select candidates, as some individuals may experience allergic reactions or psychological discomfort with certain biological agents.
Top of FormBiosurgery Market Report Highlights
- In terms of product, the surgical sealants segment accounted for 28.38% revenue share in 2024 due to their increasing use across a wide range of surgical specialties, including cardiovascular, pulmonary, and hepatic procedures.
- The soft tissue attachments segment, based on product, is projected to grow at a robust pace in the coming years, owing to the surge in the number of sports injury cases, orthopedic reconstructions, and soft tissue repair procedures.
- Based on application, the general surgery dominated the revenue market share in 2024 due to the rising penetration of abdominal, gastrointestinal, and hepatobiliary procedures that require effective bleeding control and tissue sealing.
- The cardiovascular surgery segment, in terms of application, is projected to grow at a rapid pace in the coming years, driven by the increasing prevalence of heart diseases and the rising number of open-heart and vascular procedures.
- North America accounted for 51.16% share of the global biosurgery market in 2024. This dominance is attributed to the growing prevalence of chronic diseases and an aging population.
- The U.S. held 77.79% of the North America biosurgery market share in 2024 due to high healthcare spending and a strong focus on minimally invasive procedures.
- The market in Asia Pacific is projected to grow at a robust pace in the coming years, owing to the rapidly improving healthcare infrastructure and increasing surgical procedures.
- The market in India is expanding due to rising awareness of advanced wound care and surgical hemostats.
- The market in Europe is projected to hold a substantial market share in 2034 due to established healthcare systems and high surgical volumes.
- A few global key market players include Artivion, Inc.; Aroa Biosurgery; B. Braun SE; Baxter; BD; INTEGRA LIFESCIENCES; Johnson & Johnson Services, Inc.; Medtronic; Pfizer Inc.; Sanofi; and Stryker.
Polaris Market Research has segmented the biosurgery market report on the basis of product, application, and region:
By Product Outlook (Revenue, USD Billion, 2020–2034)
- Surgical Sealants
- Hemostatic Agents
- Adhesion Barriers
- Soft Tissue Attachments
- Bone Graft Attachments
- Others
By Application Outlook (Revenue, USD Billion, 2020–2034)
- General Surgery
- Orthopedic Surgery
- Cardiovascular Surgery
- Neurological Surgery
- Others
By Regional Outlook (Revenue, USD Billion, 2020–2034)
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America